To define the mechanisms by which EMT tumour cells are resistant to chemotherapy, we assessed the expression of putative mediators of resistance to therapy in EPCAM+ and EPCAM− tumour cells from skin SCCs10,12. This evidence concerns the gene EPCAM and neoplasm.